Ignite Creation Date:
2024-05-06 @ 4:03 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02448420
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2015-05-08
Brief Title:
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Organization Data
Organization:
SOLTI Breast Cancer Research Group
Class:
OTHER
Study ID:
SOLTI-1303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SOLTI Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None